Cardinal Health, Inc. $CAH Stock Position Raised by Jacobs Levy Equity Management Inc.

Key Points

• Jacobs Levy Equity Management Inc. raised its stake in Cardinal Health by 1,186.4% during the first quarter, now owning 172,363 shares valued at approximately $23.7 million.
• Other significant increases in ownership include Wellington Management Group LLP and GAMMA Investing LLC, with increases of 1,666.7% and 17,589.1%, respectively.
• The company's latest quarterly earnings exceeded analyst expectations, reporting $2.08 EPS, with revenue of $60.16 billion, but fell short of the forecasted revenue.

Jacobs Levy Equity Management Inc. grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1,186.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 172,363 shares of the company's stock after purchasing an additional 158,964 shares during the quarter. Jacobs Levy Equity Management Inc. owned approximately 0.07% of Cardinal Health worth $23,746,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. boosted its position in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Northern Trust Corp raised its stake in Cardinal Health by 3.5% in the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after purchasing an additional 105,154 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Cardinal Health by 4.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after acquiring an additional 94,768 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Cardinal Health by 3.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after acquiring an additional 52,714 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CAH shares. Citigroup restated a "neutral" rating and issued a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Leerink Partners reduced their target price on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Bank of America increased their target price on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Finally, Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research note on Tuesday, August 12th. Eleven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $165.93.

Cardinal Health Price Performance

Shares of CAH stock traded up $2.96 on Thursday, hitting $152.25. 529,935 shares of the stock traded hands, compared to its average volume of 2,398,934. The company has a market capitalization of $36.36 billion, a PE ratio of 23.61, a PEG ratio of 1.28 and a beta of 0.73. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44. The company's fifty day moving average is $155.00 and its 200 day moving average is $147.31.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Insiders Place Their Bets

In related news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares of the company's stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 over the last three months. Company insiders own 0.09% of the company's stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.